MedPath

Efficacy of Intermittent Abdominal Pressure Ventilation in Neuromuscular Patients

Not Applicable
Recruiting
Conditions
Neuromuscular Diseases
Interventions
Device: Intermittent Abdominal Pressure Ventilation
Device: Usual ventilation
Registration Number
NCT05346263
Lead Sponsor
Fondazione Don Carlo Gnocchi Onlus
Brief Summary

Non-Invasive Ventilation (NIV) is an established treatment to manage respiratory muscles dysfunction in neuromuscular disease, preventing the progression of respiratory failure to intubation and/or a tracheotomy. NIV is commonly needed at first during the night, but when the disease worsens, it is required during the day. It is provided via nasal or oronasal masks, causing discomfort and/or aesthetic issues that result in poor compliance.

Intermittent Abdominal Pressure Ventilation (IAPV) is a valid, though unconventional, alternative to daytime NIV: it consists of a portable ventilator with an internal battery and a corset as interface. The IAPV corset is lightweight, comfortable and, thanks to velcro fasteners, easier and better fitting than a face mask. Cyclical inflation of a rubber bladder inside the corset moves the diaphragm upwards like a pneumobelt causing air to enter in the lungs via the upper airways as gravity draws the diaphragm back to its resting position.

IAPV is indicated in neuromuscular disease and has already been tested in few preliminary studies and case reports. This study wants to verify the hypothesis of its application in population of neuromuscular patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
78
Inclusion Criteria
  • Diagnosis of Neuromuscular Disease (Amyotrophic Lateral Sclerosis, Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Pompe Disease)
  • Non Invasive Ventilation > 16 hours/day
  • Informed consent signed
Exclusion Criteria
  • Diagnosis of kyphoscoliosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intermittent Abdominal Pressure VentilationIntermittent Abdominal Pressure VentilationPatients in experimental group will be adapted to Intermittent Abdominal Pressure Ventilation (IAPV). Abdominal ventilation replaces part of usual ventilation (non invasive ventilation with mouthpiece or nasal-pillow)
Usual ventilationUsual ventilationPatients in control group continue with usual ventilation (NIV through mouthpiece or nasal-pillow)
Primary Outcome Measures
NameTimeMethod
Blood Gas Analysis12 months

Changes of respiratory parameters in terms of normalization of oxyemia (Arterial Pressure of oxygen 80-100 mmHg) and normalization of capnia (Arterial Pressure of carbon dioxide 35-45 mmHg), assessed by blood gas analysis

Secondary Outcome Measures
NameTimeMethod
Therapy adherence12 months

Adherence to IAPV tested with Beliefs about Ventilation Questionnaire (BVQ). BVQ is a qualitative questionnaire: it consist of 25 items, where higher scores mean a better outcome.

Patients satisfaction to IAPV12 months

Satisfaction to IAPV tested with Visual Analog Scale (VAS), with a score that ranges between 0 and 10, where a higher score means a worse outcome.

Caregivers satisfaction to IAPV12 months

Satisfaction to IAPV tested with Visual Analog Scale (VAS), with a score that ranges between 0 and 10, where a higher score means a worse outcome.

Amelioration of Quality of life12 months

Improvement of quality of life tested with World Health Organization Quality of Life-Brief (WHOQOL-Brief), with a score ranging from 0 to 100 for each of the four domain and where a higher score means a better outcome

Trial Locations

Locations (1)

IRCCS S. Maria Nascente - Fondazione Don Carlo Gnocchi

🇮🇹

Milan, Italy

© Copyright 2025. All Rights Reserved by MedPath